Navigation Links
Bioheart, Inc. Announces Financial Results for Second Quarter 2008
Date:7/30/2008

Report on Form 10-K for the year ended December 31, 2007, as amended by Amendment No. 1 on Form 10-K/A and its quarterly report on Form 10-Q for the quarter ended March 31, 2008.

Financial Tables on Following Pages

Bioheart, Inc. and Subsidiaries

Consolidated Balance Sheets

June 30, December 31,

2008 2007

(Unaudited) (Derived from

audited

financial

statements)

ASSETS

Current assets

Cash and cash equivalents $1,879,995 $5,492,157

Receivables 53,870 52,642

Inventory 375,832 372,054

Prepaid expenses and other current assets 2,328,441 261,030

Total current assets 4,638,138 6,177,883

Property and equipment, net 370,517 444,506

Deferred offering costs - 3,484,070

Deferred loan costs, net 662,928 1,146,716

Other assets 68,854 71,148

Total assets $5,740,437 $11,324,323

LIABILITIES AND SHAREHOLDERS' DEFICIT

Current liabilities

Accounts payable $1,878,359 $2,134,256

Accrued expenses 4,436,731 4,511,775

Deferred revenue
'/>"/>

SOURCE Bioheart, Inc.
Copyright©2008 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2 3 4 5 6 7

Related biology technology :

1. Bioheart, Inc. to Report Full Year 2007 Financial Results on Thursday, March 27, 2008
2. Bioheart, Inc. Announces Financial Results for First Quarter 2008
3. Bioheart, Inc. Reports Receipt of Notification from NASDAQ Regarding Non-Compliance with Continued Listing Requirements
4. Bioheart, Inc. to Host Annual Meeting of Shareholders on Wednesday, July 30, 2008
5. Bioheart, Inc. to Transfer to Nasdaq Capital Market
6. Bioheart, Inc., Added to Russell Microcap Index
7. Bioheart, Inc., Board Appoints Howard J. Leonhardt Chief Executive Officer
8. Bioheart, Inc. to Introduce At-Home Heart Failure Monitor for Congestive Heart Failure Patients
9. Bioheart, Inc., Announces Management Change
10. Bioheart, Inc. Announces Results of Annual Meeting
11. Dendreon Announces Publication of Phase 1 Study Highlighting Immunologic and Clinical Activity of Lapuleucel-T (Neuvenge(R)) in Advanced Breast Cancer Patients

Post Your Comments:
*Name:
*Comment:
*Email:
(Date:11/5/2009).../ -- Imagenetix, Inc. (OTC Bulletin Board: IAGX), ...d CEO of Imagenetix, will be presenting the Compan... Thursday, December 3rd, at 10:30 AM PST at the Lu..., LD MICRO is a by-invitation only newsletter fir... the micro-cap space. Since 2002, the firm has pub...
(Date:11/5/2009)...ll/ -- Transgenomic, Inc. (OTC Bulletin Board: TBI...er ended September 30, 2009. The Company,s financi.... ,, Third Quarter 2009 ,, The Company rep...r the third quarter of 2009 as compared to a net l...uarter of 2008. ,, Net sales were $5.0 million...
(Date:11/5/2009)...irstCall/ -- Wound Management Technologies, Inc., ... Letter of Intent to purchase all healthcare-relat...C Bulletin Board: VHGI). The deal provides for VHG...0 shares of WNDM and a royalty agreement for reven...being acquired from VHGI. WNDM closed at $2.00 p...
(Date:11/5/2009)...pineSmith Partners has signed an initial agreement...ld that mimics the structure of natural cancellous... products by SpineSmith,s Research and Development...ffold represents a significant advancement in tech... for the delivery of adult stem cells for skeletal...
Breaking Biology Technology:Imagenetix to Present at 2nd Annual LD MICRO Conference at the Luxe Sunset Bel Air 2Transgenomic, Inc. Reports Third Quarter 2009 Results 2Transgenomic, Inc. Reports Third Quarter 2009 Results 3Transgenomic, Inc. Reports Third Quarter 2009 Results 4Transgenomic, Inc. Reports Third Quarter 2009 Results 5Transgenomic, Inc. Reports Third Quarter 2009 Results 6Transgenomic, Inc. Reports Third Quarter 2009 Results 7OTCBB-WNDM Announces LOI to Acquire VHGI Assets for $10 Million Cash/Stock 2OTCBB-WNDM Announces LOI to Acquire VHGI Assets for $10 Million Cash/Stock 3SpineSmith Partners and GenOsteo Announce Collaborative Product Development Agreement 2
...AVIV, Israel, October 15 ,Simbionix USA Corporatio...s,C round of growth capital financing led by River...r Early Stage Partners and other existing,sharehol...ed as the,company,s investment bankers. The invest...dy rapid growth of its medical simulation technolo...
...Cryo-Cell,International, Inc. (OTC Bulletin Board:... and most established family cord blood banks, tod...e months ended August 31,2008., Consolidated reve...,million compared to approximately $4.6 million fo...a net loss in the third quarter 2008 of,approximat...
...dership Position in Targeting Chemokine Receptor ...s, MOUNTAIN VIEW, Calif., Oct. 15 ChemoCentryx, ... I clinical trial of CCX025,the company,s fourth i...ered compound that inhibits the chemokine receptor...t-EN(TM) (CCX282-B; ChemoCentryx,s CCR9,antagonist...
Other Biology Technology:Simbionix Raises Largest Amount in Company's History in Venture Capital to Accelerate Growth 2Simbionix Raises Largest Amount in Company's History in Venture Capital to Accelerate Growth 3Cryo-Cell International, Inc. Reports Third Quarter 2008 Results 2Cryo-Cell International, Inc. Reports Third Quarter 2008 Results 3Cryo-Cell International, Inc. Reports Third Quarter 2008 Results 4Cryo-Cell International, Inc. Reports Third Quarter 2008 Results 5Cryo-Cell International, Inc. Reports Third Quarter 2008 Results 6ChemoCentryx Advances Second Orally Available CCR9 Antagonist CCX025 Into Clinical Development 2ChemoCentryx Advances Second Orally Available CCR9 Antagonist CCX025 Into Clinical Development 3ChemoCentryx Advances Second Orally Available CCR9 Antagonist CCX025 Into Clinical Development 4
(Date:11/4/2009)...lencoe Software, Inc., the commercial arm of the O...p://openmicroscopy.org ), is proud to announce it...Biology,s exciting new project titled "The Cell: A...M stimulus grant through the National Institutes o...art of the American Reinvestment and Recovery Act,...
(Date:11/3/2009)... published in a recent issue of HortTechnology , ... the effects of covering orchard floors with refle...light distribution, orchard temperature, and profi...enday and Solarmate films installed 5 weeks before...apples. The research showed that the use of both f...
(Date:11/3/2009)...li School of Engineering and Applied Science have ...he laboratory the enzyme responsible for producing...tin. , The research, published Oct. 23 in the...development of other compounds with similarly bene... enzyme is one of the most interesting but least u...
Breaking Biology News(10 mins):Glencoe Software to Support the ASCB 'Stimulus Grant' to Build Virtual Image Library of the Cell 2Reflective film can boost profits for apple growers 2UCLA researchers reconstitute enzyme that synthesizes cholesterol drug lovastatin 2Predictors of disease behavior change in Crohn 26 23146 3Bs disease 54046 1Potato blight plight looks promising for food security 9526 1Potato blight plight looks promising for food security 9526 2Fertility Can Be Preserved in Ovarian Cancer Patients 54043 1Fertility Can Be Preserved in Ovarian Cancer Patients 54043 2
...Researchers have created an algorithm that meshes ...ow chart of how cells respond to stimuli. Using th...ts Institute of Technology scientists have analyze...athways that can affect cell survival. Misfolded c...s are a hallmark of Parkinson,s disease. , RELEVA...
...2, 2009--Researchers at the Dana-Farber Cancer Ins...l Research (Burnham) and the Centers for Disease C...tification of human monoclonal antibodies (mAb) th...A viruses, including avian influenza A (H5N1) viru...easonal influenza viruses. These antibodies have t...
...ss., Feb. 17 LocatePLUS Holdings Corporation (Pin...ss-to-government provider of investigative, identi...ounced today the January 26, 2009 election of an e... election of a reconstituted independent Board thr...pletes a transition initiated by stockholders over...
Other Biology News:Calculating gene and protein connections in a Parkinson's disease model 2Calculating gene and protein connections in a Parkinson's disease model 3Calculating gene and protein connections in a Parkinson's disease model 4Scientists identify human monoclonal antibodies effective against bird and seasonal flu viruses 2Scientists identify human monoclonal antibodies effective against bird and seasonal flu viruses 3LocatePLUS Announces Election of Independent Board 2LocatePLUS Announces Election of Independent Board 3LocatePLUS Announces Election of Independent Board 4
Anti-Human C5 / C5b Monoclonal Antibody, Unconjugated, Clone 568 from Cell Sciences
Rabbit Anti-melatonin Antibody, Unconjugated from Cell Sciences
Rabbit Anti-melatonin Antibody, Unconjugated from Cell Sciences
Rabbit Anti-DDDDK Tag Antibody, Agarose Conjugated from MBL International
Biology Products: